Oxcarbazepine
Product Images NDC 64725-0292

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 64725-0292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0292)

Label for Oxcarbazepine 150 mg tablets, package of 100 tablets. The label shows the proprietary name, strength, and tablet count. It indicates prescription use only and mentions the manufacturer as Nexgen Pharma, Inc. The product is repackaged by TYA Pharmaceuticals, Tallahassee, FL, with contact information included. A barcode and notes on dosage instructions are also visible.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine showing a dibenzazepine core with a ketone group and an amide side chain.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier survival curve graph showing exit rate over time from Day 2 to Day 11. The graph compares two treatment groups: Oxcarbazepine (solid line) and Placebo (dashed line). The Oxcarbazepine group shows a lower exit rate over time compared to the Placebo group. The log-rank test p-value is 0.0001, indicating statistical significance between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A line chart showing seizure rates over time from first dose to first seizure, comparing Oxcarbazepine treatment group with placebo. The x-axis represents days from first dose to first seizure, and the y-axis shows the seizure rate. The graph includes a log-rank test p-value of 0.046, indicating statistical comparison between treatment groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier curve displaying exit rate over time (days) for two treatment groups labeled HIGH and LOW. The graph includes a log-rank test p-value of 0.0001, indicating statistical analysis of group differences.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve chart displaying the exit rate over time (days) for two treatment groups, labeled HIGH and LOW. The x-axis represents time to exit in days (0 to 130), and the y-axis represents the exit rate (0 to 1.0). A p-value of 0.0001 from the log-rank test is shown, indicating statistical comparison between groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.